Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Finding the right amount to invest in different cryptocurrencies is essential for a balanced portfolio. Explore ways to optimize your investments.
17,306 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
This fresh analysis explores intuit (intu) 2026 earnings, highlighting key growth drivers, profitability advances, an...
Two parallel paths are emerging in legal AI: one focused on enterprise rigor and governance, the other on broad, open...
Navigator (NVGS) 2025 earnings paint a picture of a niche LNG carrier operator balancing utilization, rates and lever...
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
A sharp move like integer stock down insider signals attention, not alarm. Learn how to read insider trades, separate...
Investors weigh income reliability and risk as markets shift. A $1.5 million portfolio that pays roughly $83,400 annu...
SunPower's Q1 2026 results could set the tone for the year. This guide explains what to watch, which numbers matter, ...
Beam Global is shaping the clean-energy charging space. In this piece, we break down what Q1 2026 earnings might reve...
As Treasury yields rise in 2026, CDL’s $2.29 annual dividend delivers reliable monthly cash flow from a diversified m...
Rising global tensions are reshaping the investment landscape. This article spotlights two defense stocks worth buyin...